DUSA PHARMACEUTICALS INC company info

CIK 879993
IRS Number 223103129
State of incorporation NJ
Business address 25 UPTON DRIVE
None
WILMINGTON
MA
01887
Mail address 25 UPTON DRIVE
None
WILMINGTON
MA
01887

Short summary

DUSA PHARMACEUTICALS INC is a Massachusetts company, with head office located at 25 Upton Drive Wilmington, Massachusetts 01887. In 2012 the company owned a total of 41.66 million USD worth of assets, including 39.76 million USD worth of current assets. An analysis of the recent trend shows a steady growth of company assets, with a 3.01% growth from the last year and a 29.35% increase in the 2 year period.

DUSA PHARMACEUTICALS INC Income Statement

Name [in Millions USD]20082009201020112012Trends
Gross Profit 22.3330.0038.37
Research and development 4.314.935.28
Operating Expenses 25.1727.2830.61
Operating Income (Loss) -2.842.737.76
Income Tax Expense (Benefit) -0.16
Net income -2.512.707.32

DUSA PHARMACEUTICALS INC Balance Sheet

Name [in Millions USD]20082009201020112012Trends
Cash and cash equivalents 3.885.6720.7426.5628.74
Accounts Receivable, Net, Current 2.162.642.77
Inventories 2.993.403.78
Total assets 32.2040.4441.66
Current assets 30.3938.4139.76
Accounts payable 1.131.111.29
Total current liabilities 5.095.495.69
Deferred Revenue, Noncurrent 1.820.890.89
Total liabilities 11.359.3511.25
Common Stock, Value, Issued 151.99151.77151.85
Retained Earnings (Accumulated Deficit) -141.15-132.49-133.91
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.050.010.01

DUSA PHARMACEUTICALS INC Cash Flow

Name [in Millions USD]20082009201020112012Trends
Net income -2.512.707.32
Depreciation and amortization 0.460.390.45
Accounts receivable 0.330.740.50
Inventories -0.43-0.020.78
Accounts payable 0.34-0.460.64
Net Cash Provided by (Used in) Operating Activities -1.783.328.04
Payments to Acquire Property, Plant, and Equipment 0.180.220.46
Net Cash Provided by (Used in) Investing Activities 5.52-2.077.22
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 5.52-2.076.47
Net Cash Provided by (Used in) Financing Activities -0.000.020.28
Cash and Cash Equivalents, Period Increase (Decrease) 3.731.2715.54